Y10S 977/802
Virus-based particle
Y10S977/802 (Virus-based particle) appears on 216 US grants and 99 published applications in this corpus.
Search patents in Y10S- Granted patents
- 216
- Published applications
- 99
- Assignees
- 130
- Inventors
- 327
- Latest grant
- 2 Jun 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 3 | 0 |
| 1996 | 5 | 0 |
| 1997 | 5 | 0 |
| 1998 | 23 | 0 |
| 1999 | 29 | 0 |
| 2000 | 18 | 0 |
| 2001 | 24 | 3 |
| 2002 | 32 | 13 |
| 2003 | 18 | 17 |
| 2004 | 5 | 11 |
| 2005 | 4 | 9 |
| 2006 | 3 | 8 |
| 2007 | 6 | 8 |
| 2008 | 3 | 5 |
| 2009 | 9 | 6 |
| 2010 | 2 | 2 |
| 2011 | 10 | 7 |
| 2012 | 4 | 4 |
| 2013 | 2 | 1 |
| 2014 | 4 | 1 |
| 2015 | 2 | 1 |
| 2016 | 1 | 1 |
| 2017 | 1 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Nanocaged enzymes with enhanced catalytic activity and increased stability2 Jun 2020US 10,669,534 B2Arizona Board of Regents on behalf of Arizona State University
- Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity1 Aug 2017US 9,718,885 B2Roche Glycart AG
- Apparatus and method for virus detection20 Dec 2016US 9,523,669 B2United Arab Emirates University
- Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity22 Sep 2015US 9,139,654 B2Roche GlyeArt AG
- Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity30 Jun 2015US 9,068,005 B2Roche Glycart AG
- Nanocaged Enzymes with Enhanced Catalytic Activity and Increased Stability18 Jan 2018US 2018/0016569 A1Arizona Board of Regents on behalf of Arizona State University
- Self-assembling nanoparticle drug delivery system4 May 2017US 2017/0119689 A1
- Glycosylation Engineering of Antibodies for Improving Antibody-Dependent Cellular Cytotoxicity21 Jul 2016US 2016/0208009 A1Roche Glycart AG
- Apparatus and method for virus detection16 Apr 2015US 2015/0104783 A1United Arab Emirates University
- Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines6 Mar 2014US 2014/0065189 A1Vical Incorporated
Most cited
By later US patents
- Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity604US 6,602,684 B1GlycArt Biotechnology AG · 2003
- Therapeutic inhibitor of vascular smooth muscle cells245US 6,171,609 B2NeoRx Corporation · 2001
- Eukaryotic layered vector initiation systems204US 5,814,482 A1998
- Virus vectors and methods of making and administering the same197US 7,172,893 B2The University of North Carolina at Chapel Hill · 2007
- Therapeutic inhibitor of vascular smooth muscle cells171US 6,515,009 B1NeoRx Corporation · 2003